SAN DIEGO, June 26, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics, Inc. (NASDAQ; SRPT) securities between June 22, 2023 and June 24, 2025, inclusive (the "Class Period"), have until August 25, 2025 to seek appointment...
Read More Details
Finally We wish PressBee provided you with enough information of ( SRPT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Sarepta Class Action Lawsuit )
Also on site :
- Tobey Maguire's 'Spider-Man' Trilogy Returns to Theaters With Rare Extended Cut
- Iconic '90s Actress, 55, Flaunts ‘Agelessly Sexy Beauty’ in Itty-Bitty String Bikini
- DNC Chair Ken Martin condemns ‘despicable’ mega-bill, calls Tillis top target in interview